Lung Cancer - Tumor Response May Not Be Best Measure Of Efficacy In Non-small Cell Lung Cancer Treatment

Tumor Response May Not Be Best Measure Of Efficacy In Non-small Cell Lung Cancer Treatment
Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness. [click link for full article]
Source: www.medicalnewstoday.com

Once promising drug for lung cancer being withdrawn from market
TORONTO (CP) - A once promising treatment for difficult-to-treat lung cancer is being essentially withdrawn from the Canadian market.
Source: ca.news.yahoo.com